Alissa Visram (@visramalissa) 's Twitter Profile
Alissa Visram

@visramalissa

ID: 1156625827456540672

calendar_today31-07-2019 18:01:01

24 Tweet

100 Followers

127 Following

Alissa Visram (@visramalissa) 's Twitter Profile Photo

At request of Linda B. Baughn May I please get 2 followers to copy and re-post this tweet? I'm trying to demonstrate that someone is always listening. #SuicidePrevention 1-800-273-8255 Just two. Any two. Copy repost, not retweet

Nina Shah (@ninashah33) 's Twitter Profile Photo

Our commentary on race. We are all a part of the conversation -might as well speak up. Thanks to Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 and Ayk for the opportunity to speak together ashclinicalnews.org/viewpoints/fro…

Robert Z. Orlowski (@myeloma_doc) 's Twitter Profile Photo

#Myeloma Paper of the Day: Family history of plasma cell disorders is associated with an improved overall survival in #MGUS, multiple #myeloma, and systemic AL #amyloidosis: pubmed.ncbi.nlm.nih.gov/34764424/.

#Myeloma Paper of the Day: Family history of plasma cell disorders is associated with an improved overall survival in #MGUS, multiple #myeloma, and systemic AL #amyloidosis: pubmed.ncbi.nlm.nih.gov/34764424/.
Robert Z. Orlowski (@myeloma_doc) 's Twitter Profile Photo

#Myeloma Paper of the Day: Study assessing prognostic utility of serial smoldering #myeloma risk stratification scores finds patients evolving to high-risk category progress more often and may benefit from early intervention approaches: pubmed.ncbi.nlm.nih.gov/34836942/.

#Myeloma Paper of the Day: Study assessing prognostic utility of serial smoldering #myeloma risk stratification scores finds patients evolving to high-risk category progress more often and may benefit from early intervention approaches: pubmed.ncbi.nlm.nih.gov/34836942/.
Bruno Paiva (@brunopaiva_unav) 's Twitter Profile Photo

Important study in smoldering #myeloma published by Mayo in Blood Cancer Journal Risk is dynamic and should be reassessed yearly. Authors acknowledged the limitation of marrow assessment only at baseline Solution➡️CTCs. That is our aim in the iMMunocell project nature.com/articles/s4140…

Important study in smoldering #myeloma published by Mayo in <a href="/BloodCancerJnl/">Blood Cancer Journal</a>
Risk is dynamic and should be reassessed yearly. Authors acknowledged the limitation of marrow assessment only at baseline
Solution➡️CTCs. That is our aim in the iMMunocell project
nature.com/articles/s4140…
C. Ola Landgren, M.D. (@drolalandgren) 's Twitter Profile Photo

Importance of serial testing in myeloma precursor disease from prospective NCI PLCO study: jamanetwork.com/journals/jamao… Results confirmed and expanded by large independent Mayo Clinic study. #mmsm ⁦International Myeloma Foundation⁩ ⁦Multiple Myeloma RF⁩ ⁦Sigurdur Kristinsson⁩ nature.com/articles/s4140…

Jason Leclair (@jasonmleclair) 's Twitter Profile Photo

Amazing that these two have been working so hard to keep people well and the hospital running from the very start of the pandemic. Thanks Samantha Halman and Isabelle Desjardins; you are absolute The Ottawa Hospital superstars! ottawa.ctvnews.ca/the-women-led-…

Robert Z. Orlowski (@myeloma_doc) 's Twitter Profile Photo

#Myeloma Paper of the Day: Monoclonal proteinuria may help to predict progression risk in asymptomatic multiple #myeloma patients with a free light chain ratio ≥100: pubmed.ncbi.nlm.nih.gov/35190659/.

#Myeloma Paper of the Day: Monoclonal proteinuria may help to predict progression risk in asymptomatic multiple #myeloma patients with a free light chain ratio ≥100: pubmed.ncbi.nlm.nih.gov/35190659/.
Nina Shah (@ninashah33) 's Twitter Profile Photo

Important analysis on impact of marginalization on treatment timing and survival in a universal medical system. So many complicated factors but steps to access (not just access itself) probably among the most important. Congrats to Alissa Visram Hira Mian #mmsm #IMS2022

Important analysis on impact of marginalization on treatment timing and survival in a universal medical system. So many complicated factors but steps to access (not just access itself) probably among the most important. Congrats to <a href="/VisramAlissa/">Alissa Visram</a> <a href="/HiraSMian/">Hira Mian</a> #mmsm #IMS2022
Daniel Auclair (@auclairdan) 's Twitter Profile Photo

Important discussion by Dr. Alissa Visram at #IMS2022 on the impact of marginalization on treatment receipt and OS in NDMM in a population-based Ontario, Canada cohort #mmsm

Important discussion by Dr. Alissa Visram at #IMS2022 on the impact of marginalization on treatment receipt and OS in NDMM in a population-based Ontario, Canada cohort #mmsm
Noopur Raje (@noopurrajemd) 's Twitter Profile Photo

Fantastic session on induction for #mmsm #IMS2022: transplant, maintenance, frailty impacting treatment choice, and access to care for marginalized populations.. special shout out to Dr. Visram for a great presentation.

Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

COVID amplified disparities in healthcare access and availability in the US, leading to disparities in outcomes by race and ethnicity.

Hira Mian (@hirasmian) 's Twitter Profile Photo

Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) Database with @ArleighMccurdy Alissa Visram Victor H Jimenez-Zepeda Julie Stakiw Canadian Myeloma Research Group Annette Hay onlinelibrary.wiley.com/doi/10.1002/jh…